ZUG, Switzerland, June 2 /CNW/ - Patheon Inc. (TSX: PTI), a global
provider of drug development and manufacturing services to the international
pharmaceutical industry, is pleased to announce that its site in
Bourgoin-Jallieu, France was recently recognized by Eli Lilly and Company as
an outstanding supplier and business partner. Patheon received the Lilly
Supplier Award for Excellence during an awards ceremony held at Lilly's
Aldo Braca, President, European Operations for Patheon stated,
"Relationships such as the one Patheon holds with Eli Lilly and Company are
critical to our success as a company and to ensuring we give our clients the
best service available. We are honored to be recognized as a key supplier for
Lilly and thank the company for recognizing Patheon's efforts."
ABOUT PATHEON INC.
Patheon Inc. (TSX: PTI; www.patheon.com) is a leading global provider of
contract development and manufacturing services to the pharmaceutical
industry. Patheon prides itself in providing the highest quality products and
services to more than 300 pharmaceutical and biotechnology companies.
Patheon's services range from preclinical development through the commercial
manufacturing of a wide array of dosage forms including parenteral, solid,
semi-solid and liquids. Patheon's comprehensive range of fully integrated
Pharmaceutical Development Services includes pre-formulation, formulation,
analytical development, clinical manufacturing, scale-up and
commercialization. Patheon's ability to integrate development and
manufacturing services ensures that our customers' projects are delivered on
time and meet the high standards of quality that Patheon is known for.
Patheon's integrated development and manufacturing network of 10
facilities and 7 development centers, across North America and Europe, strives
to ensure that customer products can be launched timely and confidently
anywhere in the world.
For further information:
For further information: Mr. Wes Wheeler, President & Chief Executive
Officer, Tel: (919) 226-3200, Email: email@example.com; Mr. Eric Evans,
Chief Financial Officer, Tel: (919) 226-3200, Email: firstname.lastname@example.org;
Mr. Aldo Braca, President of Europe, Tel: +39 (0775) 399 201, Email: